Josh Jennings
Stock Analyst at TD Cowen
(2.26)
# 2,986
Out of 4,361 analysts
1073
Total ratings
43.8%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Reiterated: Buy | $34 | $26.76 | +27.06% | 30 | Jun 1, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Hold | $163 | $144.43 | +12.86% | 21 | May 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $80 → $61 | $47.68 | +27.94% | 75 | May 29, 2026 | |
| CERS Cerus | Reiterated: Buy | $5 | $2.70 | +85.19% | 36 | May 27, 2026 | |
| DXCM DexCom | Maintained: Buy | $75 | $73.45 | +2.11% | 36 | May 27, 2026 | |
| MDWD MediWound | Reiterated: Buy | $25 | $13.76 | +81.69% | 28 | May 27, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | n/a | $87.66 | - | 69 | May 21, 2026 | |
| MDT Medtronic | Reiterated: Buy | $119 | $73.75 | +61.36% | 68 | May 20, 2026 | |
| BAX Baxter International | Maintained: Hold | $20 | $18.68 | +7.07% | 36 | May 18, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $5.5 | $4.19 | +31.26% | 31 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.97 | +153.81% | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $68.45 | +75.31% | 67 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.91 | +283.63% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 → $1.5 | $1.39 | +7.91% | 44 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $9.29 | +61.46% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $17.50 | +65.71% | 22 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $5.07 | +97.24% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $34.45 | +59.67% | 22 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $70.41 | +34.92% | 48 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.87 | +118.34% | 12 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.58 | +31.00% | 31 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $86.97 | +32.23% | 69 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $222.89 | +12.16% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $20 | $7.48 | +167.38% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $142.43 | +166.10% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $293.30 | +48.31% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.745 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $0.7294 | +722.59% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $18.60 | +7.53% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $99 | $83.75 | +18.21% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3982 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.48 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24.85 | $9.00 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $13 | $1.03 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $127.57 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.34 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.000001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $0.591 | n/a | 1 | Mar 18, 2015 |
PROCEPT BioRobotics
Jun 1, 2026
Reiterated: Buy
Price Target: $34
Current: $26.76
Upside: +27.06%
Becton, Dickinson and Company
May 29, 2026
Reiterated: Hold
Price Target: $163
Current: $144.43
Upside: +12.86%
Boston Scientific
May 29, 2026
Maintained: Buy
Price Target: $80 → $61
Current: $47.68
Upside: +27.94%
Cerus
May 27, 2026
Reiterated: Buy
Price Target: $5
Current: $2.70
Upside: +85.19%
DexCom
May 27, 2026
Maintained: Buy
Price Target: $75
Current: $73.45
Upside: +2.11%
MediWound
May 27, 2026
Reiterated: Buy
Price Target: $25
Current: $13.76
Upside: +81.69%
Edwards Lifesciences
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $87.66
Upside: -
Medtronic
May 20, 2026
Reiterated: Buy
Price Target: $119
Current: $73.75
Upside: +61.36%
Baxter International
May 18, 2026
Maintained: Hold
Price Target: $20
Current: $18.68
Upside: +7.07%
AVITA Medical
May 15, 2026
Reiterated: Buy
Price Target: $5.5
Current: $4.19
Upside: +31.26%
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.97
Upside: +153.81%
May 13, 2026
Maintained: Buy
Price Target: $120
Current: $68.45
Upside: +75.31%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $3.91
Upside: +283.63%
May 13, 2026
Reiterated: Buy
Price Target: $1 → $1.5
Current: $1.39
Upside: +7.91%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $9.29
Upside: +61.46%
May 11, 2026
Reiterated: Buy
Price Target: $29
Current: $17.50
Upside: +65.71%
May 8, 2026
Rated: Buy
Price Target: $12 → $10
Current: $5.07
Upside: +97.24%
May 7, 2026
Reiterated: Buy
Price Target: $55
Current: $34.45
Upside: +59.67%
May 6, 2026
Maintained: Buy
Price Target: $95
Current: $70.41
Upside: +34.92%
May 5, 2026
Maintained: Buy
Price Target: $15
Current: $6.87
Upside: +118.34%
Apr 30, 2026
Reiterated: Buy
Price Target: $6
Current: $4.58
Upside: +31.00%
Apr 29, 2026
Maintained: Buy
Price Target: $115
Current: $86.97
Upside: +32.23%
Apr 23, 2026
Maintained: Buy
Price Target: $250
Current: $222.89
Upside: +12.16%
Jan 23, 2026
Maintained: Buy
Price Target: $27 → $20
Current: $7.48
Upside: +167.38%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $142.43
Upside: +166.10%
Nov 13, 2025
Maintained: Buy
Price Target: $435
Current: $293.30
Upside: +48.31%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.745
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: $6
Current: $0.7294
Upside: +722.59%
Nov 6, 2025
Maintained: Buy
Price Target: $20
Current: $18.60
Upside: +7.53%
Nov 5, 2025
Maintained: Hold
Price Target: $104 → $99
Current: $83.75
Upside: +18.21%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.3982
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.48
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $24.85
Current: $9.00
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $15 → $13
Current: $1.03
Upside: n/a
Oct 29, 2020
Maintained: Buy
Price Target: $80
Current: $127.57
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.34
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.000001
Upside: n/a
Mar 18, 2015
Maintained: Buy
Price Target: $9
Current: $0.591
Upside: n/a